Jeffery Wyzykowski
About Jeffery
Jeff Wyzykowski is a patent agent in the life sciences practice group and a member of Cooley's litigation department. He joined Cooley in 2005 and is resident in the Washington, DC office. Jeff specializes in patent counseling issues including due diligence, patentability and freedom to operate opinions.
Experience
- 
                    
MapLight Therapeutics Announces $258.9 Million IPO and Concurrent Private Placement
 - 
                    
Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals
 - 
                    
Zenas BioPharma Announces $225 Million IPO
 - 
                    
Alto Neuroscience Announces $147.9 Million IPO
 - 
                    
Blue Owl Capital Invests up to $1.05 Billion in BridgeBio Pharma
 
Admissions and credentials
- Registered to practice before the United States Patent and Trademark Office (USPTO)
 
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.